Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
The CRISPR gene-editing company Editas Medicine has signed a sponsored research agreement with Broad Institute of MIT and Harvard. The deal stipulates that the institute could receive up to $125 million and Editas will have the first right to license Broad inventions arising from the sponsored research. Editas currently owes Broad two payments totaling $12.5 million. The agreement comes after Broad scientists Feng Zhang and David Liu, who are also cofounders of Editas, launched three new companies this year based on their CRISPR inventions.
This article has been sent to the following recipient: